Remove Compounding Remove Patient Care Remove Pharmaceutical Companies Remove Webinar
article thumbnail

The digital transformation of pharma’s physician engagement strategies

pharmaphorum

The pandemic has ushered in a number of major changes to healthcare systems, notably in the ways in which pharmaceutical companies communicate, visit and engage with physicians. The threat of disease spread and other risk factors from COVID-19 have only compounded this. How engagement with HCPs will evolve in the future.

article thumbnail

Digital strategies for pharma’s physician engagement

pharmaphorum

A recent pharmaphorum webinar on digital transformation , held in association with P360, explored how COVID has fast-tracked pharma’s long-held ambitions to make wider use of digital technology and streamline its communications with HCPs. Physician access issues coupled with message delivery disconnects only compounded the problem.